-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Candel Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q1 2023.
- Candel Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $230K, a 39.4% increase year-over-year.
- Candel Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $778K, a 235% increase from 2021.
- Candel Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $232K, a 155% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)